Vetoquinol Universal Registration Document 2019

2 46   Vetoquinol  Universal Registration Document 2019  Financial report STATEMENT OF NON-FINANCIAL PERFORMANCE Carbon footprint 2.5.2 Waste management Solid waste is monitored closely by means of detailed indicators and changes are analyzed in order to prevent anomalies. In accordance with the waste sorting policy, materials such as wood, cardboard, paper, metal and electrical and electronic equipment are sent to recy- cling companies. Pharmaceutical waste, which cannot be recycled, is incinerated at a certified energy recycling facility. The best way to treat waste is to reuse it: Vetoquinol prioritizes this solution and has already rolled out a procedure for pallets, transport containers, printing paper, etc. The Group’s production plants currently recycle around 33% of their waste, not including energy recycling via incineration. The volume of industrial waste in 2019 was slightly greater than in 2018, mainly due to the inclusion of the Angers facility in the reporting scope and the increased amount of production scrap requiring destruction at Lure. Vetoquinol aims to reduce the volume of waste at source and increase the recycling rate by stepping up waste sorting at all facilities and seeking new out- sourced recycling solutions. 2.5.2.1 Hazardous (HIW) and non-hazardous (NHIW) industrial waste per country (in tons) 2017 2018 2019 France Canada Poland Italy Brazil Total HIW NHIW HIW NHIW HIW NHIW HIW NHIW HIW HIW NHIW NHIW 303 341 245 83 15 33 38 36 8 4 338 298 315 543 487 457 10 8 15 20 31 30 78 72 68 28 27 31 35 17 31 66 44 212 219 290 2019 data includes the Angers R&D center. 2017 and 2018 have not been restated in view of the limited contribution from Angers. The data reported in the 2018 statement of non-financial performance, which is partly based on estimates made at the reporting date, has been restated in accor- dance with actual values. 2.5.2.2 Combustible gas consumption (kWh) 2017 2018 2019 France Canada Poland Italy Brazil Total 11,864 11,376 10,935 2,439 2,612 2,689 4,469 4,205 4,114 675 609 584 62 216 244 18,384 19,690 19,017 2019 data includes the Angers R&D center. 2017 and 2018 have not been restated in view of the limited contribution from Angers. The data reported in the 2018 statement of non-financial performance, which is partly based on estimates made at the reporting date, has been restated in accor- dance with actual values.